4.8 Article

Suppression of microRNA activity amplifies IFN-γ-induced macrophage activation and promotes anti-tumour immunity

Journal

NATURE CELL BIOLOGY
Volume 18, Issue 7, Pages 790-+

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/ncb3371

Keywords

-

Categories

Funding

  1. Fonds National Suisse de la Recherche Scientifique [FNS 31003A-143978, FNS 31003A-165963]
  2. Fondation pour la lutte contre le cancer
  3. FNS [IZK0Z3_160843/1]
  4. Swiss Federal Commission for Scholarships for Foreign Students (Swiss Government Excellence Scholarship) [2015.0430]
  5. Swiss National Science Foundation (SNF) [IZK0Z3_160843] Funding Source: Swiss National Science Foundation (SNF)

Ask authors/readers for more resources

Tumour-associated macrophages (TAMs) largely express an alternatively activated (or M2) phenotype, which entails immunosuppressive and tumour-promoting capabilities. Reprogramming TAMs towards a classically activated (M1) phenotype may thwart tumour-associated immunosuppression and unleash anti-tumour immunity. Here we show that conditional deletion of the microRNA (miRNA)-processing enzyme DICER in macrophages prompts M1-like TAM programming, characterized by hyperactive IFN-gamma/STAT1 signalling. This rewiring abated the immunosuppressive capacity of TAMs and fostered the recruitment of activated cytotoxic T lymphocytes (CTLs) to the tumours. CTL-derived IFN-gamma exacerbated M1 polarization of Dicer1-deficient TAMs and inhibited tumour growth. Remarkably, DICER deficiency in TAMs negated the anti-tumoral effects of macrophage depletion by anti-CSF1R antibodies, and enabled complete tumour eradication by PD1 checkpoint blockade or CD40 agonistic antibodies. Finally, genetic rescue of Let-7 miRNA activity in Dicer1-deficient TAMs partly restored their M2-like phenotype and decreased tumour-infiltrating CTLs. These findings suggest that DICER/Let-7 activity opposes IFN-gamma-induced, immunostimulatory M1-like TAM activation, with potential therapeutic implications.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available